In conclusion, TIM-3 expression of AML blasts correlated positively with TIM-3 expression of T lymphocytes and the proportion of CD8+ T lymphocyte, indicating TIM-3 might alter adaptive immunity of AML patients. Here, HAVCR2 is linked to acute myeloid leukemia.